These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 17083556

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The use of intravitreal bevacizumab to treat choroidal neovascular membranes (CNVMs).
    Derriman L, Marshall J, Moorman C, Downes SM.
    Retina; 2008 Jun; 28(6):910; author reply 910-1. PubMed ID: 18536613
    [No Abstract] [Full Text] [Related]

  • 3. Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks.
    Rinaldi M, Dell'Omo R, Romano MR, Chiosi F, Cipollone U, Costagliola C.
    Arch Ophthalmol; 2007 Oct; 125(10):1422-3. PubMed ID: 17923555
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effect of treatments given to patients before initiation of anti-vascular endothelial growth factor treatment.
    Hedaya J, Freeman WR.
    Retina; 2008 Jun; 28(6):911-2; author reply 912. PubMed ID: 18536615
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Intravitreal bevacizumab for the management of choroidal neovascularization in pseudoxanthoma elasticum.
    Bhatnagar P, Freund KB, Spaide RF, Klancnik JM, Cooney MJ, Ho I, Fine HF, Yannuzzi LA.
    Retina; 2007 Sep; 27(7):897-902. PubMed ID: 17891014
    [Abstract] [Full Text] [Related]

  • 8. Clinical course of choroidal neovascularization secondary to angioid streaks treated with intravitreal bevacizumab.
    Teixeira A, Mattos T, Velletri R, Teixeira R, Freire J, Moares N, Bonomo PP.
    Ophthalmic Surg Lasers Imaging; 2010 Sep; 41(5):546-9. PubMed ID: 20795575
    [Abstract] [Full Text] [Related]

  • 9. Choroidal neovascularization in angioid streaks and pseudoxanthoma elasticum: 1 year follow-up.
    Schiano Lomoriello D, Parravano MC, Chiaravalloti A, Varano M.
    Eur J Ophthalmol; 2009 Sep; 19(1):151-3. PubMed ID: 19123166
    [Abstract] [Full Text] [Related]

  • 10. Intravitreal bevacizumab (Avastin) in choroidal neovascular membrane in angioid streaks.
    Sachdev N, Vishwanathan K, Gupta V, Singh R, Gupta A.
    Indian J Ophthalmol; 2007 Sep; 55(6):457-8. PubMed ID: 17951904
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of choroidal neovascularization in pathologic myopia with intravitreal bevacizumab.
    Laud K, Spaide RF, Freund KB, Slakter J, Klancnik JM.
    Retina; 2006 Oct; 26(8):960-3. PubMed ID: 17031300
    [No Abstract] [Full Text] [Related]

  • 13. Intravitreal bevacizumab for peripapillary classic subretinal neovascularization.
    Spandau UH, Jonas JB.
    Acta Ophthalmol Scand; 2007 May; 85(3):340-1. PubMed ID: 17488467
    [No Abstract] [Full Text] [Related]

  • 14. Intravitreal bevacizumab for the treatment of choroidal neovascularization secondary to angioid streaks: one year of follow-up.
    El Matri L, Kort F, Bouraoui R, Karim B, Chebil A, Chaker N.
    Acta Ophthalmol; 2011 Nov; 89(7):641-6. PubMed ID: 21155980
    [Abstract] [Full Text] [Related]

  • 15. Intravitreal bevacizumab for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration.
    Bom Aggio F, Eid Farah M, Melo GB.
    Acta Ophthalmol Scand; 2006 Oct; 84(5):713-4. PubMed ID: 16965511
    [No Abstract] [Full Text] [Related]

  • 16. Intravitreal bevacizumab for treatment of choroidal neovascularization in pathologic myopia.
    Tewari A, Dhalla MS, Apte RS.
    Retina; 2006 Oct; 26(9):1093-4. PubMed ID: 17151505
    [No Abstract] [Full Text] [Related]

  • 17. Intravitreal aflibercept for refractory choroidal neovascularization secondary to angioid streaks.
    Tetikoglu M, Sagdik HM, Aktas S, Ozcura F.
    Eye (Lond); 2016 Jun; 30(6):894-5. PubMed ID: 26939555
    [No Abstract] [Full Text] [Related]

  • 18. Long-term outcomes of intravitreal antivascular endothelial growth factor therapy for the management of choroidal neovascularization in pseudoxanthoma elasticum.
    Myung JS, Bhatnagar P, Spaide RF, Klancnik JM, Cooney MJ, Yannuzzi LA, Freund KB.
    Retina; 2010 May; 30(5):748-55. PubMed ID: 19996818
    [Abstract] [Full Text] [Related]

  • 19. Intravitreal avastin: the low cost alternative to lucentis?
    Rosenfeld PJ.
    Am J Ophthalmol; 2006 Jul; 142(1):141-3. PubMed ID: 16815262
    [No Abstract] [Full Text] [Related]

  • 20. Intravitreal bevacizumab (Avastin) for choroidal neovascularization in angioid streaks: a case series.
    Donati MC, Virgili G, Bini A, Giansanti F, Rapizzi E, Giacomelli G, Menchini U.
    Ophthalmologica; 2009 Jul; 223(1):24-7. PubMed ID: 18849633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.